Menses and breast cancer: Does timing of mammographically directed core biopsy affect outcome?

Journal of Surgical Oncology

Volumn 74, Issue 3, 2000, Pages 232-236

  Macleod, Jana ^a,c   Fraser, Ron ^a   Horeczko, Natalie ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Breast Mammography Center   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Mammography; Menstrual cycle; Prognostic indicators

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; FEMALE; FOLLICULAR PHASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENSTRUATION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; BIOPSY; BREAST NEOPLASMS; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MAMMOGRAPHY; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0033897398     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200007)74:3<232::AID-JSO16>3.0.CO;2-I     Document Type: Article

References (35)

1. The EBCTCG overview of adjuvant therapy of breast cancer
2. Estrous influence on surgical cure of a mouse breast cancer
3. Menstrual influence on surgical cure of breast cancer
4. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer
5. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free excision during the menstrual cycle influences duration of disease-free survival
6. Breast cancer detection demonstration project data can determine whether the prognosis of breast cancer is affected by the time of surgery during the menstrual cycle
7. Timing of surgery in relation to menstrual cycle in premenopausal women with operable breast cancer
8. Effect of menstrual cycle phase on surgical treatment of breast cancer
9. Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - Fact or fallacy
10. Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer
11. Effect of menstrual phase on surgical treatment of breast cancer
12. Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer
13. Timing of breast cancer surgery within the menstrual cycle: Influence of lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence
14. Timing of surgery for breast cancer and menstrual cycle
15. Timing of surgery for breast cancer and menstrual cycle
16. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients
17. Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 premenopausal women
18. The timing of breast cancer surgery within the menstrual cycle
19. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas
20. Menstrual timing of breast cancer surgery
21. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle
22. Cyclic tumor variations in premenopausal women with early breast cancer
23. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions
24. Comparison of histologic diagnosis between stereotactic core needle biopsy and open surgical biopsy
25. Internal detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen
26. Surgical adjuvant chemotherapy. Results of one short course with cyclophosphamide after mastectomy for breast cancer
27. Peri-operative hormones and prognosis in breast cancer
28. Wound healing: Biologic and clinical features
29. Induction of plasminogen activator in human breast cancer cell line (MCF-7)
30. Fibrin formation and dissolution in women receiving oral contraceptive drugs
31. Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease
32. Depressed mononuclear cell phagocytic activity associated with menstruation
33. Autocrine and paracrine growth regulation of human breast cancer